Tag Archives: Small Molecule Innovator CDMO Market

Due to the rising demand for outsourcing pharmaceutical development and manufacturing services, the small molecule innovator contract development and manufacturing organization (CDMO) market is expected to grow at a CAGR of 6.5% from 2023 to 2031. Innovative pharmaceutical companies are increasingly relying on CDMOs to accelerate drug development timelines, gain access to specialized expertise, and optimize manufacturing. Small molecule drugs ...